Clinical Trial Update: Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE) [NA]

View source ↗

Summary

This clinical trial evaluates whether NETosis biomarkers can predict thrombosis risk in patients with myeloproliferative neoplasms and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Myeloproliferative Neoplasm, Myeloproliferative Disorders | NA | Status: RECRUITING